Physician
Psychiatry
Dr. Bankole A. Johnson, MD
|
|
Give Review
Bankole Johnson works in the field of Psychiatry. Doctor Bankole A. Johnson, MD is a published doctor as well. He has 91 publications published. The latest was: Alcohol-medical drug interactions.
Publications
- Analyzing repeated measures semi-continuous data, with application to an alcohol dependence study.
- Cumulative Proportion of Responders Analysis (CPRA) as a Tool to Assess Treatment Outcome in Alcohol Clinical Trials.
- The efficacy of a low dose combination of topiramate and naltrexone on ethanol reinforcement and consumption in rat models.
- Association, interaction, and replication analysis of genes encoding serotonin transporter and 5-HT3 receptor subunits A and B in alcohol dependence.
- Topiramate for the Treatment of Cocaine Addiction: A Randomized Clinical Trial.
- Topiramate's effects on cocaine-induced subjective mood, craving and preference for money over drug taking.
- Penalized likelihood estimation for semiparametric mixed models, with?application to alcohol treatment research.
- Obtaining the optimal dose in alcohol dependence studies.
- Fine-grain analysis of the treatment effect of topiramate on methamphetamine addiction with latent variable analysis.
- Serotonin transporter genomic biomarker for quantitative assessment of ondansetron treatment response in alcoholics.
- Topiramate for the treatment of methamphetamine addiction: a multi-center placebo-controlled trial.
- Impact of Motivational Changes on Drinking Outcomes in Pharmacobehavioral Treatment for Alcohol Dependence.
- Severity of drinking as a predictor of efficacy of the combination of ondansetron and topiramate in rat models of ethanol consumption and relapse.
- Pharmacogenetic approach at the serotonin transporter gene as a method of reducing the severity of alcohol drinking.
- Medication treatment of different types of alcoholism.
- Drinking histories in alcohol-use-disordered youth: preliminary findings on relationships to platelet serotonin transporter expression with genotypes of the serotonin ...
- Susceptibility locus in neurokinin-1 receptor gene associated with alcohol dependence.
- New weapon to curb smoking: no more excuses to delay treatment.
- Understanding and treating alcohol dependence.
- Treating smoking dependence in depressed alcoholics.
- Effects of repeated-dose isradipine on the abuse liability of cocaine.
- Comorbid alcohol and nicotine dependence: from the biomolecular basis to clinical consequences.
- Challenges and opportunities for medications development in alcoholism: an international perspective on collaborations between academia and industry.
- Use of oral topiramate to promote smoking abstinence among alcohol-dependent smokers: a randomized controlled trial.
- Acute intravenous low- and high-dose cocaine reduces quantitative global and regional cerebral blood flow in recently abstinent subjects with cocaine use disorder.
- The COMBINE SAFTEE: a structured instrument for collecting adverse events adapted for clinical studies in the alcoholism field.
- Isradipine decreases the hemodynamic response of cocaine and methamphetamine results from two human laboratory studies: results from two human laboratory studies.
- Emerging biomarkers: new directions and clinical applications.
- Safety and efficacy of GABAergic medications for treating alcoholism.
- Pharmacists'' and technicians'' perceptions and attitudes toward dispensing buprenorphine/ naloxone to patients with opioid dependence.
- A pilot evaluation of the safety and tolerability of repeat dose administration of long-acting injectable naltrexone (Vivitrex) in patients with alcohol dependence.
- Oral topiramate reduces the consequences of drinking and improves the quality of life of alcohol-dependent individuals: a randomized controlled trial.
- Progress in the development of topiramate for treating alcohol dependence: from a hypothesis to a proof-of-concept study.
- Relative bioavailability of an extemporaneous ondansetron 4-mg capsule formulation versus solution.
- Effects of isradipine on cocaine-induced subjective mood.
- Serotonin-3 receptors in the actions of alcohol, alcohol reinforcement, and alcoholism.
- Development of novel pharmacotherapies for the treatment of alcohol dependence: focus on antiepileptics.
- Ondansetron reduces mood disturbance among biologically predisposed, alcohol-dependent individuals.
- Dose-ranging kinetics and behavioral pharmacology of naltrexone and acamprosate, both alone and combined, in alcohol-dependent subjects.
- Genetics of alcoholism using intermediate phenotypes.
- Drugs, the Brain, and Behavior: the Pharmacology of Abuse and Dependence. Edited by John Brick and Carlton Erickson. 186 pp., illustrated. New York: Haworth Medical Pr...
- Comment on 'Health aspects of cannabis: revisited' (Hollister).
- Preliminary Evidence for cue-induced Alcohol Craving Modulated by Serotonin Transporter Gene Polymorphism rs1042173.
- Alcohol-medical drug interactions.
- Should the reorganization of addiction-related research across all the National Institutes of Health be structural?--The devil is truly in the details.
- How Should Addiction-Related Research at the National Institutes of Health be Reorganized?
- Association between Genotype of the Serotonin Transporter-Linked Polymorphic Region of the Serotonin Transporter Gene and Age of Onset of Methamphetamine Use: a Prelim...
- Topiramate in the new generation of drugs: efficacy in the treatment of alcoholic patients.
- Effect of topiramate treatment on ethanol consumption in rats.
- Recent advances in the development of treatments for alcohol and cocaine dependence: focus on topiramate and other modulators of GABA or glutamate function.
- A preliminary randomized, double-blind, placebo-controlled study of the safety and efficacy of ondansetron in the treatment of methamphetamine dependence.
- Evaluating readiness and treatment seeking effects in a pharmacotherapy trial for alcohol dependence.
- Update on neuropharmacological treatments for alcoholism: scientific basis and clinical findings.
- Topiramate for treating alcohol dependence: a randomized controlled trial.
- Can serotonin transporter genotype predict serotonergic function, chronicity, and severity of drinking?
- A multi-level two-part random effects model, with application to an alcohol-dependence study.
- World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Substance Use and Related Disorders, Part 1: Alcoholism.
- A Double-Blind, Placebo-Controlled Trial Assessing the Efficacy of Varenicline Tartrate for Alcohol Dependence.
- Naltrexone long-acting formulation in the treatment of alcohol dependence.
- Improvement of physical health and quality of life of alcohol-dependent individuals with topiramate treatment: US multisite randomized controlled trial.
- Prediction of serotonergic treatment efficacy using age of onset and Type A/B typologies of alcoholism.
- Characterization of a functional polymorphism in the 3'' UTR of SLC6A4 and its association with drinking intensity.
- Can serotonin transporter genotype predict craving in alcoholism?
- Effects of topiramate on methamphetamine-induced changes in attentional and perceptual-motor skills of cognition in recently abstinent methamphetamine-dependent indivi...
- Topiramate reduces the harm of excessive drinking: implications for public health and primary care.
- Kinetic and cardiovascular effects of acute topiramate dosing among non-treatment-seeking, methamphetamine-dependent individuals.
- A preliminary randomized, double-blind, placebo-controlled study of the safety and efficacy of ondansetron in the treatment of cocaine dependence.
- Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial.
- A synopsis of the pharmacological rationale, properties and therapeutic effects of depot preparations of naltrexone for treating alcohol dependence.
- Pills for speedballing or cocaine dependence.
- Effects of acute topiramate dosing on methamphetamine-induced subjective mood.
- An overview of medications for the treatment of alcohol withdrawal and alcohol dependence with an emphasis on the use of older and newer anticonvulsants.
- Reductions in and relations between "craving" and drinking in a prospective, open-label trial of ondansetron in adolescents with alcohol dependence.
- The role of serotonergic agents as treatments for alcoholism.
- Effects of isradipine, a dihydropyridine-class calcium-channel antagonist, on d-methamphetamine''s subjective and reinforcing effects.
- Uses of topiramate in the treatment of alcohol dependence.
- Effects of isradipine on cocaine-induced changes in cognitive performance in recently abstinent cocaine-dependent individuals.
- A prospective, open-label trial of ondansetron in adolescents with alcohol dependence.
- Effects of isradipine on methamphetamine-induced changes in attentional and perceptual-motor skills of cognition.
- Role of the serotonergic system in the neurobiology of alcoholism: implications for treatment.
- Platelet serotonin uptake and paroxetine binding among allelic genotypes of the serotonin transporter in alcoholics.
- Kinetic and cardiovascular comparison of immediate-release isradipine and sustained-release isradipine among non-treatment-seeking, cocaine-dependent individuals.
- An overview of the development of medications including novel anticonvulsants for the treatment of alcohol dependence.
- Topiramate-induced neuromodulation of cortico-mesolimbic dopamine function: a new vista for the treatment of comorbid alcohol and nicotine dependence?
- Bankole A Johnson interview.
- Current status of carbohydrate deficient transferrin, total serum sialic acid, sialic acid index of apolipoprotein J and serum beta-hexosaminidase as markers for alcoh...
- Pharmacotherapeutic trials in adolescent alcohol use disorders: opportunities and challenges.
- Oral topiramate for treatment of alcohol dependence: a randomised controlled trial.
- The role of anxiety in predicting drinking behaviour.
- Ondansetron reduces the craving of biologically predisposed alcoholics.
Schools
University Of Glasgow Faculty Of Medicine
Houston
Doctors Specialties
- Psychiatry
Accepted Insurances
Hospital
-
University of Virginia Medical Center
Helpful Reviews
Similar Doctors
|
Dr. E Virginia Bayliss, MD |
|
|
Dr. Joseph J. David, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Preska M. Moore, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. R S. Pearce, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Nickie M. Spears, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Charles D. Moseley, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Daniel H. Josephthal, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Anthony J. Forgey, DO |
|
|
Dr. Alexa A. Reames, MD
This Doctor is OpenDoctor Recommended.
|